毛细支气管炎患儿免疫功能状态评价的意义

被引:21
作者
刘雅丽 [1 ]
杨锡强 [2 ]
机构
[1] 杭州市第一人民医院儿科
[2] 重庆医科大学儿童医院
关键词
毛细支气管炎; 细胞因子; TH1细胞; TH2细胞;
D O I
暂无
中图分类号
R725.6 [小儿呼吸系及胸部疾病];
学科分类号
100202 ;
摘要
目的探讨毛细支气管炎(毛支)患儿的免疫功能状态的意义。方法采用酶联免疫吸附分析法(ELISA)和逆转录聚合酶链反应(RT-PCR)测定25例毛支患儿外周血单个核细胞体外产生IL-12、18、10、4,IFN-γ及血浆IgE的水平及膜表面蛋白分子淋巴细胞活化基因3(LAG-3)mRNA的表达。门诊体检的健康儿童14例作为正常对照组。结果毛支患儿急性期IL-12 (390.94±95.88)ng/L及II-18(146.23±55 81)ng/L水平明显低于正常对照组[(452.44±195.07)、(246.69±121.29)ng/L] (P<0.05),IL-10(302.40±100.04)ng/L、IL-4(30.52±17.65)ng/L及IgE(82.90±51.4)ng/L水平明显升高(P分别<0.05, 0.01,0.05),IFN-γ(103.25±82.15)ng/L水平虽低于正常对照组,但无显著差异(P>0.05)。IFN-γ/IL-4比率(3.6±0.9:1.0) 较对照组(9.7±2.1:1.0)降低约3倍(P<0.05)。TH1细胞表面标记LAG-3 mRNA的表达明显低(P<0.05)。结论毛支患儿存在TH1/TH2失衡、TH1功能下降、TH2功能占优势的状态,与APC的功能状态及其所分泌的上游调控细胞因子(IL-12、18、 10)的平衡紊乱有关。
引用
收藏
页码:584 / 586
页数:3
相关论文
共 16 条
[1]  
Current and emerging nonsteroidal anti-in- flammatory therapies targeting specific mechanisms in asthma and al-lergy. Bjermer L,Diamant Z. Treatments in Respiratory Medicine . 2004
[2]   毛细支气管炎细胞因子与发病机理的研究 [J].
符州 ;
李成荣 ;
杨锡强 .
免疫学杂志, 1999, (01) :42-44
[3]  
Respiratory syncytial virus infection and asthma. Martin MA. Al- lergol Immunopathol . 2001
[4]  
Effects of interleukin - 18 on asthmatic airway inflammation. Zhang H,Zhang Z,Xu Y. Chinese Medical Journal . 2003
[5]  
Low numbers of interleukin - 12 - producing cord blood mononuclear cells and im-munoglobulin E sensitization in early childhood. Nilsson C,Larsson AK,Hoglind A,et al. Clinical and Experimental Allergy . 2004
[6]  
Respiratory development of 5 to 6 year - old children experiencing a first bronchiolitis episode before age one. Sznajder M,Stheneur C,Albonico V,et al. Allerg Immunol (Paris) . 2005
[7]  
Interliukin (IL) - 18 promotes the development of chronic gastrointestinal helminth infection by downre-gulating IL- 13. Helena H,Kiyoshi T,Shizuo A,et al. The Journal of Experimental Medicine . 2001
[8]  
Decreased inter-liukin - 12 levels in umbilical cord blood in children who developed a-cute broncholitis. Blanco -Quriros A,Gonzalez H,Arranz E,et al. Pediatric Pulmonology . 1999
[9]  
In vitro responsiveness to IL-18 in combination with IL - 12 or IL - 2 by PBMC from patients with bronchial asthma and atopic dermatitis. El-Mezayen RE,Matsumoto T. Clinical Immunology . 2004
[10]  
IL- 12 p40 and IL- 18 modulate inflammatory and immune responses to respiratory syncytial virus infection. Wang SZ,Bao YX,Rosenberger CL. J Immunol . 2004